Literature DB >> 28332471

CJD surveillance in the Republic of Ireland from 2005 to 2015: a suggested algorithm for referrals.

Teresa Loftus, Daphne Chen, Seamus Looby, Albi Chalissery, Rachel Howley, Ciara Heaney, Josephine Heffernan, Michael Farrell, Francesca Brett.   

Abstract

Definitive diagnosis of Creutzfeldt Jakob disease (CJD) remains tissue-based. Possible and probable CJD are useful clinical terms but may be used indiscriminately. The aim of this study was to assess the effectiveness of the Irish surveillance system and to ascertain how diagnostic accuracy in identifying clinically "definite" cases might be improved. We reviewed the clinical information, relevant investigations, and samples n = 100; (autopsy n = 87; biopsy n = 13) in 96 patients between January 1, 2005 and December 31, 2015. In 4 cases both a biopsy and autopsy were performed. CJD was confirmed in 50 patients (45 at autopsy and 5 at biopsy). Sporadic CJD (sCJD) accounted for 90% of cases (n = 45); variant CJD (vCJD) for 6% (n = 3) with 1 case each of familial CJD and iatrogenic CJD. CSF 14-3-3, EEG, and MRI investigations were helpful but not available on all patients. CJD mimics (n = 46) fell into the following categories: neurodegenerative (n = 22), immune mediated (n = 3), cerebrovascular disease (n = 5), tumor (n = 5), dual pathology (n = 3), and miscellaneous (n = 8). The Irish surveillance system fulfils its main objective as all clinically suspicious cases are being referred. CJD was confirmed in 52% (n = 50/96) of referrals. Based on this, we propose an algorithm for CJD referrals to reduce both infection control and diagnostic difficulties encountered in CJD surveillance.
.

Entities:  

Mesh:

Year:  2017        PMID: 28332471     DOI: 10.5414/NP301016

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  7 in total

1.  Brain biopsies requiring Creutzfeldt-Jakob disease precautions in the Republic of Ireland 2005-2016.

Authors:  F M Brett; S Looby; A Chalissery; D Chen; C Heaney; J Heffernan; F Cunningham; R Howley; T Loftus; H Kearney; M A Farrell
Journal:  Ir J Med Sci       Date:  2017-08-12       Impact factor: 1.568

2.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

Review 3.  Intravascular large B-cell lymphoma presenting clinically as rapidly progressive dementia.

Authors:  F M Brett; D Chen; T Loftus; Y Langan; S Looby; S Hutchinson
Journal:  Ir J Med Sci       Date:  2017-07-19       Impact factor: 1.568

Review 4.  Neuropathology correlates of cognitive assessments.

Authors:  Francesca M Brett; Hugh Kearney
Journal:  Ir J Med Sci       Date:  2018-01-18       Impact factor: 1.568

5.  EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.

Authors:  Francesca M Brett; Richard Flavin; Daphne Chen; Teresa Loftus; Seamus Looby; Allan McCarthy; Cillian de Gascun; Elaine S Jaffe; Nurul Nor; Mohsen Javadpour; Dominick McCabe
Journal:  Hum Pathol (N Y)       Date:  2017-11

6.  Sporadic Creutzfeldt-Jakob disease presenting as dizziness and cognitive decline: A case report.

Authors:  Yuhao Xu; Jianhui Xu; Jian Zhang; Zhirong Cai; Hong Wei; Ming Yu; Yuefeng Li
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  Analysis of 22 Years of Surveillance for Prion Diseases in Slovenia, 1996 to 2017.

Authors:  Nuška Čakš Jager; Mara Popović; Mateja Blaško Markič; Alenka Kraigher
Journal:  Zdr Varst       Date:  2018-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.